The closing price of HashiCorp Inc (NASDAQ: HCP) was $26.10 for the day, down -0.95% from the previous closing price of $26.35. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 1360711 shares were traded.
Ratios:
Our analysis of HCP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 12, 2024, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $31.
Morgan Stanley Upgraded its Equal-Weight to Overweight on February 26, 2024, whereas the target price for the stock was revised from $23 to $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 02 ’24 when Dadgar Armon sold 35,904 shares for $25.69 per share. The transaction valued at 922,392 led to the insider holds 1,661,164 shares of the business.
Dadgar Armon sold 35,904 shares of HCP for $972,629 on Mar 22 ’24. The CHIEF TECHNOLOGY OFFICER now owns 1,697,068 shares after completing the transaction at $27.09 per share. On Mar 22 ’24, another insider, Dadgar Armon, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 25,956 shares for $27.09 each. As a result, the insider received 703,122 and left with 118,864 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCP now has a Market Capitalization of 5.21B and an Enterprise Value of 3.94B. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.97 while its Price-to-Book (P/B) ratio in mrq is 4.29. Its current Enterprise Value per Revenue stands at 6.76 whereas that against EBITDA is -16.10.
Stock Price History:
Over the past 52 weeks, HCP has reached a high of $36.39, while it has fallen to a 52-week low of $18.91. The 50-Day Moving Average of the stock is 25.32, while the 200-Day Moving Average is calculated to be 24.46.
Shares Statistics:
HCP traded an average of 2.44M shares per day over the past three months and 1.39M shares per day over the past ten days. A total of 125.33M shares are outstanding, with a floating share count of 113.23M. Insiders hold about 43.49% of the company’s shares, while institutions hold 47.24% stake in the company. Shares short for HCP as of Mar 15, 2024 were 6.46M with a Short Ratio of 2.83, compared to 5.45M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.24% and a Short% of Float of 5.24%.
Earnings Estimates
The firm’s stock currently is rated by 17 analysts. On average, analysts expect EPS of -$0.01 for the current quarter, with a high estimate of $0.01 and a low estimate of -$0.03, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between $0.2 and $0.01 for the fiscal current year, implying an average EPS of $0.07. EPS for the following year is $0.27, with 18 analysts recommending between $0.62 and $0.1.
Revenue Estimates
A total of 17 analysts have provided revenue estimates for HCP’s current fiscal year. The highest revenue estimate was $647.04M, while the lowest revenue estimate was $643.61M, resulting in an average revenue estimate of $645.56M. In the same quarter a year ago, actual revenue was $583.14M, up 10.70% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $754.72M in the next fiscal year. The high estimate is $777.51M and the low estimate is $730.7M. The average revenue growth estimate for next year is up 16.90% from the average revenue estimate for this year.
